Singapore, Singapore

Subhra Kumar Biswas

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Agency for Science, Technology and Research. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subhra Kumar Biswas. Retrieved from https://idiyas.com/inventor/subhra-kumar-biswas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Subhra Kumar Biswas

Introduction

Subhra Kumar Biswas is a prominent inventor based in Singapore, known for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has made remarkable advancements in the development of antigen binding proteins.

Latest Patents

His latest patents include the development of IL-1β neutralizing human monoclonal antibodies. This invention is directed to antigen binding proteins, specifically targeting IL-1β. The patent further provides compositions comprising these antigen binding proteins, their uses, and methods for production. This innovative work has the potential to impact therapeutic approaches in various medical conditions.

Career Highlights

Subhra Kumar Biswas is affiliated with the Agency for Science, Technology and Research, where he continues to push the boundaries of scientific research and innovation. His work is characterized by a commitment to advancing healthcare solutions through biotechnology.

Collaborations

He has collaborated with notable colleagues, including Cheng-I Wang and Angeline Goh, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Subhra Kumar Biswas exemplifies the spirit of innovation in biotechnology, with his patents paving the way for future advancements in medical treatments. His contributions are invaluable to the scientific community and the field of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…